Background: A total of 775 consecutive non-duplicate isolates of Enterobacteriaceae (534 E.
INTRODUCTION
The β-lactams are a critically important class of antimicrobial agents utilized worldwide for the treatment of serious hospital-and community-acquired infections (1) . The predominant mechanism for resistance to these antibiotics in gram-negative bacteria is the production of various plasmid-mediated β-lactamases, especially Ambler class A and class C β-lactamase genes. Plasmid-mediated AmpC β-lactamases (pAmpCs) are derived from chromosomal ampC genes of several members of the family Enterobacteriaceae, including Citrobacter freundii, Enterobacter cloacae, Morganella morganii, and Hafnia alvei. These pAmpCs have been reported from various clinical isolates with increasing frequency (2) . E. cloacae, S. marcescens and C. freundii are important nosocomial pathogens which naturally harbour chromosomal ampC genes. The data regarding coproduction of extended-spectrum β-lactamases (ESBLs) and pAmpCs in E. cloacae, S. marcescens and C. freundii are fragmentary (3) (4) (5) . Several studies have described that the dissemination of genes encoding plasmid-mediated β-lactamase is mediated by mobile genetic elements carried by large transferable plasmids (6, 7) . In light of the above facts, the present extensive study was planned to determine the prevalence of pAmpCs, the co-presence of ESBLs and mobile genetic elements, like class 1 integrons, ISCR1 and ISEcp1 in E. cloacae, S. marcescens and C. freundii isolates.
MATERIALS AND METHODS

Bacterial isolates
A total of 775 consecutive non-duplicate isolates of Enterobacteriaceae (534 E. cloacae, 137
S. marcescens and 104 C. freundii) were collected from 2005 to 2014 at 34 hospitals in Anhui Province, China. Anhui Province locates in eastern China with the permanent population of about 60.829 million and covers the area of 139,600 square kilometers. All hospitals were more than 800 beds. Species identification was performed with the Vitek 2 system (bioMérieux, Marcy l'Étoile, France) and confirmed with API 20E identification (bioMérieux, Marcy l'Étoile, France).
Antimicrobial susceptibility testing
For the clinical isolates and transconjugants analyzed in this study, the minimum inhibitory 
Conjugation experiments
Conjugation was done as described by Barguigua using sodium azide-resistant E. coli J53 (E. coli J53AZ R ) as the recipient strain (9) . Donor strains in the logarithmic phase of growth were mixed with recipients in early stationary phase at a 1:10 ratio in Muller-Hinton broth (Oxiod, UK), and the conjugation mixtures were incubated at 37 ℃ for 14 h. Transconjugants were selected on tryptone soya agar supplemented with sodium azide (100μg/ml, to inhibit growth of the donor strain) and FOX (16μg/ml, to inhibit growth of the recipient strain), which were incubated for approximately 20 h at 37℃. Tranconjugants were identified with pAmpC ß-lactamases in Enterobacteriaceae API 20E and Vitek-2 system. Transconjugants producing AmpC-type β-lactamases were detected by PCR using purified plasmid DNA as the template, ultimately sequenced and tested for susceptibility as described above for the clinical isolates.
Investigation of resistance determinants
The detection of AmpC β-lactamase was based on the AmpC enzyme inhibitor screening method (10) . Plasmids DNAs were extracted from the AmpC screened-positive isolates and transconjugants using the Qiagen plasmid purification kit (Qiagen, Hilden, Germany). Genes encoding 6 phylogenetic groups of acquired AmpC enzymes were sought with a multiplex PCR assay (11) . Different β-lactamase genes (including bla CTX-M , bla TEM , bla SHV and bla OXA )
and mobile elements such as class 1 integrons, ISCR1 and ISEcp1 were analyzed by PCR using primers as described previously for the isolates carrying pAmpCs (9, 12, 13) . Detection of the bla IPM in pAmpCs producers was performed by PCR amplification. The purified PCR products were ligated with pUC118-Teasy vectors (TaKaRa, China), which were amplified in E. coli DH5a. All nucleotide sequences were sequenced by the dideoxy chain termination method using an ABI Prism 3730 sequence analyzer (Applied Biosystems, Foster City, CA).
Sequence alignment was compared with the GenBank nucleotide database using the nucleotide BLAST program. The sequences of class 1 integron were analyzed by PCR-RFLP.
After culturing the pAmpCs producers and ultrasonication, outer membrane proteins were extracted. Then, SDS-PAGE electrophoresis was performed and stained with Coomassie brilliant blue. The difference between the outer membrane proteins of clinical isolates was compared with E. cloacae ATCC 13047.
Southern hybridizations of transconjugants
The plasmids extracted from pAmpCs producers and their transconjugants by the rapid alkaline lysis protocol were digested with Pst I restriction enzyme (TaKaRa, China). The with PCR-generated probes whose sequences were specific internal regions of the bla DHA-1 ,
, and bla OXA-1 genes fragments, respectively.
The nonradioactive enhanced chemilumine-scence random prime kit (Boster, China) was used to label the DNA probes (20 ng/mL) and for detection. mg/L to >256 mg/L. In addition, several of pAmpCs producers showed resistance to CIP and AMK. 53 transconjugants exhibited an increase in the MICs of β-lactams compared to the recipients. The transconjugants as well as pAmpCs producers present the similar resistance spectrum except for fluoroquinolones (Table 1) . With regard to the genotypes, the most pAmpC ß-lactamases in Enterobacteriaceae 6 prevalent pAmpCs producers were 39 bla DHA-1 , followed by 24 bla ACT-1 . Then, the bla ampC genotypes of transconjugants were bla DHA-1 (n=37), next to bla ACT-1 (n=23) ( Table 2) .
RESULTS
Rates
Different other β-lactamases genes of 63 pAmpCs producers and 53 transconjugants screened by PCR using specific primers and identified by DNA sequencing were summarized in Table 3 . Out of the pAmpC-positive isolates and transconjugants, a total of 23 E. cloacae and 19 transconjugants from E. cloacae were found to carry at least one of these β-lactamase genes. The dominant β-lactamase genes in this study were TEM-1 and SHV- The structure of intI1-bla ampC -ISCR1-bla in integrons is the most frequently detected in 11 transconjugants carrying 2 kinds of β-lactamases genes. Then, the other 8 transconjugants encoding several of β-lactamases genes presented the structural forms of intI1-bla ampC -bla-ISCR1-ISEcp1 -bla.
DISCUSSION
To the best of our knowledge, this is the first systematic molecular survey reporting the prevalence of pAmpCs E. cloacae, S. marcescens and C. freundii isolates. A prevalence rate of pAmpCs was 8.1% overall for these chromosomal AmpC-producing isolates which implied the extensive dissemination of pAmpC-producing bacteria in China. Regrettably, many studies lay emphasis on inducible AmpC-producers or derepressed AmpC mutants and neglect pAmpCs that are often expressed in large amounts and are encoded by transposons that can be easily transferred among bacteria. This study demonstrated that most of the pAmpCs genes were successfully transferred on transferable plasmids to the recipients. An increase in the MICs of β-lactam was detected in the transconjugants compared to the recipients. It is suggested that the dissemination of the pAmpCs is mostly due to the transmission of plasmids by horizontal exchange. Consequently, the rapid spread of pAmpCs by plasmids raises clinical concern among Enterobacteriaceaes, especially K. pneumoniae and E. coli which are known for lacking or poorly expressing chromosomal AmpC β-lactamase genes (2). We detected a dominance of DHA-1 which had been mostly reported from Asia. It had been found existing in the plasmids of these chromosomal AmpC-producing Enterobacteriaceaes as well (3, 14) . bla MIR and bla ACT previously were thought to be 85 to 87% identity with most chromosomal AmpC enzymes in E. cloacae (15) .
However, conjugative plasmid-mediated bla MIR and bla ACT were detected in E. cloacae in our study, which were rarely reported before.
Several researches have shown a close association between pAmpCs and ESBLs (3).
We observed that a total of 23 isolates can produce both pAmpCs and β-lactamases simultaneously, which is in accordance with previous reports. The coexistence of different classes of β-lactamases in a single isolate can cause failure of treatment because these combinations restrict the range of available therapeutic options to some extent (16) . ISCR1
elements have been found adjacent to a number of cephalosporinase genes, including class A β-lactamase genes especially CTX-M and class C β-lactamase such as DHA, CMY and MOX (17) . ISCR1 appears to be unusual in the sense that it is almost always found in a complex class 1 integron structure, which has been the most prevalent combination in our study. We found that all ISEcp1-positive isolates produce both intI1 integrase gene encoded in a class 1 integron and ISCR1. In a recent study by Bae Ik et al, it was shown that a bla CTX-M-14 gene was found on a complex class 1 integron and proceeded by a partial copy of ISEcp1 in addition to a complete copy of ISCR1 element in E. coli contained 3 β-lactamase genes including bla DHA-1 , bla , and bla CTX-M-14 (18 lead to the result of plasmid-mediated transferring blaampC.
In conclusion, this is the first report describing the prevalence of pAmpCs among chromosomal AmpC-producing isolates. The concurrent occurrence of β-lactamases and the frequent association with mobile genetic elements, indicate a complex antibiotic resistance mechanism in these Enterobacteriaceaes. In our study, although plasmids were demonstrated to be the main vehicles for the dissemination of pAmpC genes among different bacteria, various mobile genetic elements may also play an important role in the prevalence of these enzymes. 
